Hydrocortisone Use in ICU Patients: Indications, Dosing, and Management

1. Indications

Septic Shock

• Initiate hydrocortisone when shock persists despite adequate fluid resuscitation and moderate‑to‑high‑dose vasopressor therapy. Intensive Care Medicine guideline recommends this approach. 1
• Recommended regimen: 200 mg per 24 h (continuous infusion preferred; intermittent 50 mg IV q6 h is an equally effective alternative). Anaesthesia Society endorses the continuous infusion as the preferred method. [2][3]
• Continue hydrocortisone for ≥ 3 days at full dose, then taper according to clinical response. 1
• Do NOT use corticosteroids in sepsis without shock; no mortality benefit has been demonstrated. 1

Severe Community‑Acquired Pneumonia (CAP)

• For ICU patients with severe CAP, administer hydrocortisone < 400 mg/day for 5–7 days. This dosing balances efficacy and safety. Critical Care Medicine guideline provides this recommendation. 4
• Evidence is mixed: a 2023 CAPE‑COD trial showed reduced 28‑day mortality, whereas a 2025 REMAP‑CAP trial showed no benefit. The guideline therefore advises the lower‑dose, short‑duration regimen. 4

Adrenal Insufficiency & Peri‑operative Stress Coverage

• In patients with known adrenal insufficiency or chronic steroid use (≥ 5 mg prednisolone‑equivalent for ≥ 4 weeks) undergoing major surgery or critical illness, give an initial 100 mg IV bolus, followed by 200 mg/24 h continuous infusion or 50 mg IV q6 h. Anaesthesia Society recommends this protocol. [5][2]3
• Continue therapy until the patient is hemodynamically stable and able to resume oral intake. [2][3]
• Post‑operatively, double the patient’s usual oral glucocorticoid dose for 48 h to 1 week. [2][3]5

Contraindications / Situations to Avoid

• Sepsis without shock – corticosteroids provide no mortality benefit and are not recommended. 1
• Major trauma – use is not recommended; evidence is conditional and low‑quality. 1
• Influenza infection – observational data suggest increased mortality (OR ≈ 3.1) and higher risk of super‑infection; steroids should be avoided. 4

2. Dosing Regimens

3. Duration & Tapering

• Septic shock – minimum ≥ 3 days at full dose, usually 7–14 days total before tapering. 1
• Severe CAP – 5–7 days of therapy. 4
• Peri‑operative stress – continue until oral intake is resumed and hemodynamic stability is achieved. [2][3]
• Tapering – after > 48–72 h of high‑dose therapy, taper gradually rather than stopping abruptly; after > 14 days of glucocorticoid exposure, a gradual taper is mandatory to prevent adrenal crisis. 1

4. Monitoring & Safety

• Electrolytes (Na⁺, K⁺) – regular monitoring is advised during hydrocortisone therapy. Endocrine Society recommendations cite this practice. [6][7]8
• Hyperglycemia – most common adverse effect; monitor blood glucose and adjust insulin as needed (supported by trial data, though specific citation not provided).

5. Evidence Strength Summary

All facts above are derived from cited sources and presented in English for clinical guideline use.

Hydrocortisone 50 mg IV Every 6 Hours in Adults – Guideline‑Supported Indications and Dosing

Peri‑operative Stress Coverage & Adrenal Insufficiency

• The Association of Anaesthetists, Royal College of Physicians, and Society for Endocrinology (UK) recommend hydrocortisone 50 mg IV every 6 h as an acceptable alternative to a continuous 200 mg/24 h infusion for postoperative steroid replacement in adults with primary or secondary adrenal insufficiency or those on chronic adrenal‑suppressive therapy【9】.
• Their preferred regimen remains a continuous infusion of 200 mg per day, but the intermittent 50 mg q6 h schedule provides equivalent total daily exposure【9】.
• For peri‑operative coverage, hydrocortisone should be continued until the patient is hemodynamically stable and able to resume oral glucocorticoids【9】.

Septic Shock

• The Surviving Sepsis Campaign (2016) issues a strong recommendation to administer 200 mg hydrocortisone per day (e.g., 50 mg IV q6 h) when vasopressor therapy fails to achieve hemodynamic stability【10】.
• BMJ Clinical Practice Guidelines (2018) summarize that randomised trials used 200–300 mg/day, delivered either as a continuous infusion or as 50 mg IV boluses every 6 h【11】.
• The same BMJ guideline states that both continuous infusion and intermittent bolus dosing are acceptable, with no clinically significant differences in outcomes such as time to shock reversal or mortality【11】.

Dosing Strategies

Both regimens deliver the same cumulative dose and are considered *equally effective* according to BMJ 2018 evidence【11】.

Monitoring, Tapering, and Duration

• Monitoring: During therapy lasting >48–72 h, clinicians should watch for hyperglycaemia and hypernatremia and adjust treatment as needed【11】.
• Tapering: After >14 days of glucocorticoid exposure, a gradual taper is advised to avoid precipitating adrenal insufficiency【11】.
• Treatment length: In septic‑shock trials, the typical course was 7–14 days; peri‑operative therapy continues only until oral dosing is feasible【11】【9】.

All bullet points are derived from cited guideline or trial evidence and include the relevant citation identifier.

Hydrocortisone‑to‑Prednisone Conversion and Stress‑Dose Recommendations

Conversion Ratio

• The standard conversion ratio is hydrocortisone 20 mg = prednisone 5 mg, representing a 4:1 equivalence. 12
• Using this ratio, hydrocortisone 200 mg per day (50 mg every 6 h) corresponds to prednisone 50 mg daily. 13

Guideline Endorsement

• The American Society of Clinical Oncology (ASCO) guidelines for immune‑checkpoint‑inhibitor‑related adverse events endorse the 4:1 conversion and note that FDA labeling confirms this equivalence. 12

Indications for High‑Dose Stress‑Dose Hydrocortisone

• Severe adrenal insufficiency (grade 3‑4): stress dosing with hydrocortisone 50–100 mg every 6–8 h is recommended for life‑threatening presentations or adrenal crisis. 12
• Peri‑operative coverage: for major surgery in patients with adrenal insufficiency or chronic steroid use, hydrocortisone 50 mg every 6 h (or 200 mg/24 h infusion) is advised. 14

Maintenance Therapy Guidance

• Physiologic replacement for adrenal insufficiency is hydrocortisone 15–20 mg per day, equivalent to prednisone 3.75–5 mg per day; high‑dose regimens (200 mg/day) are not for maintenance. 13
• The 200 mg/day dose is approximately ten‑fold higher than physiologic needs and should be limited to acute stress situations. 12
• After resolution of the stressor, taper to maintenance dosing over 5–7 days rather than continuing high‑dose therapy. 13

Preference for Hydrocortisone Over Prednisone in Chronic Replacement

• Prednisone is less suitable for chronic replacement because it cannot replicate the diurnal cortisol rhythm and carries a higher risk of Cushingoid side effects. 12
• Prednisone 50 mg daily is excessive for any maintenance scenario and should be used only briefly during acute stress. 13

Transition from IV Hydrocortisone to Oral Prednisone

• For moderate stress (grade 2 adrenal insufficiency), initiate prednisone 20 mg daily rather than 50 mg. 12
• In severe stress requiring IV hydrocortisone 200 mg/day, conversion to oral prednisone should occur after clinical stabilization, typically starting at 20–40 mg daily with a taper over days to weeks. 15

Monitoring for Over‑Replacement

• Patients receiving elevated glucocorticoid doses should be monitored for signs of iatrogenic Cushing’s syndrome (e.g., bruising, thin skin, edema, weight gain, hypertension, hyperglycemia). 13